China, Sept. 18 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'FihoeLix S- equol capsule is helpful to improve the efficacy and safety of perimenopausal syndrome'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600132763
Registration Time: 2026/09/18
Type: Interventional study
Primary Sponsor: Hangzhou Red Cross Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=343252
Published by HT Digital Content Services with permission from Health Daily Digest....